The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Biomarker-Integrated Umbrella, Advanced Gastric Cancer
Official Title: The Master Protocol for Biomarker-Integrated Umbrella Trial in Advanced Gastric Cancer
Study ID: NCT02951091
Brief Summary: In-depth understanding of molecular characteristics of gastric cancer enabled us to realize personalized medicine with targeted agents in gastric cancer treatment.The investigators initiated open-label, randomized, controlled phase II, multi-arm trial comparing targeted therapy based on tumor molecular profiling with standard paclitaxel therapy as second line treatment.
Detailed Description:
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center, Seoul, , Korea, Republic of
Name: Sun Young Rha, Ph.D
Affiliation: Severance Hospital
Role: PRINCIPAL_INVESTIGATOR